TGR5 signalling in heart and brain injuries: focus on metabolic and ischaemic mechanisms
The heart and brain are the core organs of the circulation and central nervous system, respectively, and play an important role in maintaining normal physiological functions. Early neuronal and cardiac damage affects organ function. The relationship between the heart and brain is being continuously...
Gespeichert in:
Veröffentlicht in: | Neurobiology of disease 2024-03, Vol.192, p.106428-106428, Article 106428 |
---|---|
Hauptverfasser: | , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The heart and brain are the core organs of the circulation and central nervous system, respectively, and play an important role in maintaining normal physiological functions. Early neuronal and cardiac damage affects organ function. The relationship between the heart and brain is being continuously investigated. Evidence-based medicine has revealed the concept of the “heart- brain axis,” which may provide new therapeutic strategies for certain diseases. Takeda protein-coupled receptor 5 (TGR5) is a metabolic regulator involved in energy homeostasis, bile acid homeostasis, and glucose and lipid metabolism. Inflammation is critical for the development and regeneration of the heart and brain during metabolic diseases. Herein, we discuss the role of TGR5 as a metabolic regulator of heart and brain development and injury to facilitate new therapeutic strategies for metabolic and ischemic diseases of the heart and brain.
•There is a brain-heart axis and organ damage may be reduced by intervening fluid changes in brain and heart injury.•TGR5 is widely distributed in various types of cells, and is closely related to the metabolism and injury of brain and heart.•TGR5 may play a key role in brain and heart diseases, which become a potential treatment for diseases related to the brain and heart. |
---|---|
ISSN: | 0969-9961 1095-953X |
DOI: | 10.1016/j.nbd.2024.106428 |